Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT05170919
PHASE2

Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Sponsor: Englewood Hospital and Medical Center

View on ClinicalTrials.gov

Summary

To determine whether olanzapine or mirtazapine is more effective in preventing weight loss and appetite loss in cancer patients.

Official title: An Efficacy Study Comparing Olanzapine and Mirtazapine in the Improvement of Unintentional Weight Loss for Patients with Advanced Stage Cancer

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

170

Start Date

2022-01-20

Completion Date

2026-12

Last Updated

2024-09-19

Healthy Volunteers

No

Interventions

DRUG

Mirtazapine

Patients will be prescribed a dosage of 15 mg per day. Dose will not be escalated.

DRUG

Olanzapine

the participant will be prescribed a dosage of 2.5mg per day if \> 65 yrs. and 5 mg/per day if \<65 yrs. per day. Per physician discretion, participants are allowed a dose escalation of a maximum of 10mg.

Locations (1)

Englewood Health

Englewood, New Jersey, United States